Gathe JC, Hardwicke RL, Garcia F, Weinheimer S, et al. Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1: A Phase 2a study. J Acquir Immune Defic Syndr 2021;Publish Ahead of Print.
PMID: 33427765